Denali Therapeutics
DNLI
DNLI
128 hedge funds and large institutions have $1.41B invested in Denali Therapeutics in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 54 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
14% more capital invested
Capital invested by funds: $1.23B → $1.41B (+$175M)
2.55% more ownership
Funds ownership: 73.79% → 76.34% (+2.5%)
24% less call options, than puts
Call options by funds: $367K | Put options by funds: $483K
Holders
128
Holding in Top 10
4
Calls
$367K
Puts
$483K
Top Buyers
| 1 | +$57.1M | |
| 2 | +$27M | |
| 3 | +$19.4M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$14.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.9M |
Top Sellers
| 1 | -$68.2M | |
| 2 | -$6.56M | |
| 3 | -$1.64M | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$792K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$791K |